about
Advances in Diagnosis and Treatments for Immune ThrombocytopeniaImmune thrombocytopenia: epidemiological and clinical features of 216 patients in northwestern Turkey.A novel acquired inv(2)(p23.3q24.3) with concurrent submicroscopic deletions at 2p23.3, 2p22.1, 2q24.3 and 1p13.2 in a patient with chronic thrombocytopenia and anemiaHigh frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology.MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia.Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.Qian Five Rhinoceros Gindeng (QFRG) protects against development of immune thrombocytopenia via miR-181a inhibition of TLR-4 expressionRelation of interleukin-10 Promoter Polymorphisms to Adult Chronic Immune Thrombocytopenic Purpura in a Cohort of Egyptian Population.Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT.Factors associated with the effect of open splenectomy for immune thrombocytopenic purpura.A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia.Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.Gammaplex® 5 and 10% in the treatment of primary immunodeficiency and chronic immune thrombocytopenic purpura.Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.Spleen tyrosine kinase inhibition: a new promising approach to chronic and refractory immune thrombocytopenia.Fostamatinib for persistent/chronic adult immune thrombocytopenia.The Role of Hydroxychloroquine as a Steroid-sparing Agent in the Treatment of Immune Thrombocytopenia: A Review of the Literature.Clinical characteristics and treatment courses for cytomegalovirus-associated thrombocytopenia in immunocompetent children after neonatal period.
P2860
Incidence and Outcome of Severe and Nonsevere Thrombocytopenia Associated With Zika Virus Infection-Puerto Rico, 2016A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case reportOptimal use of thrombopoietin receptor agonists in immune thrombocytopeniaAntigenic Mimicry in Paraneoplastic Immune ThrombocytopeniaHematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related ThrombocytopeniaCB2 Receptor Stimulation and Dexamethasone Restore the Anti-Inflammatory and Immune-Regulatory Properties of Mesenchymal Stromal Cells of Children with Immune ThrombocytopeniaFamilial Immune Thrombocytopenia Associated With a Novel Variant inDisseminated tuberculosis with severe immune thrombocytopeniaAutoimmune Cytopenias in Pediatric Hematopoietic Cell Transplant PatientsIndirubin modulates CD4 T-cell homeostasis via PD1/PTEN/AKT signalling pathway in immune thrombocytopenia
P921
Q26738630-4D01BA1D-2B38-4231-BA1D-D17D81698B3CQ33417741-5B640A2C-B6DA-4AAE-9DEC-07FB6FD0BF76Q33420184-6F0EBA29-405F-48ED-A816-758A7BCA5334Q33423096-CC105794-E306-481B-A8B7-2DD0D0C3BFECQ33423573-82267F8A-A8F2-49D9-B67C-0EA11F4A9DF5Q33424731-F5EC3314-4B27-4521-B77B-C9393DCCF828Q33424810-E8F16F98-D816-4772-9486-149C9ED7417EQ33426471-BD6F5438-C803-43C7-B990-FBA65B118A90Q33427006-6BF9E85A-7030-421F-880D-7021870E1029Q33432631-FE51D1B0-A8A0-4BAE-8E76-281AD7FC5EB6Q33442065-9311A27B-BDB2-4D45-B7D8-EAA56F8A18ECQ33442354-404F728F-871F-4EF1-BF52-998095D437B6Q50070347-3893720A-E15D-4DD6-871D-947C2CE39D23Q52562217-85730BC9-AB43-47DD-B83B-23B4363FF50FQ52764290-88C60093-DFE1-48F6-BCFB-BC142ED44758Q54144290-4C687457-2F18-472F-A03D-469A6C20A895Q55129731-F06FB7EA-EA9D-4992-99B6-82B79CA21431Q55384953-F523526D-83DF-4D62-B9EE-A451609932E9
P2860
Q60921167-CAA43A72-F4EA-47C4-A5FD-D31BFF145347Q61808218-12419BFC-6D15-405C-A90B-C3B0BB406CD7Q64057585-A2F4619B-1040-4ADF-985D-759F76771226Q64060959-06BCD76E-7720-44CE-8F4E-6E91FA45E11EQ64085283-11ABE4B3-04BB-4E20-8F92-5DD242BEEB3AQ64088574-9F8B4434-923E-4A00-98B0-BEDDDE0C9B3CQ64093812-950EB22B-56A7-42AB-9BE8-D08C2AD2D00FQ64106818-1A5E8958-ED05-4DEE-B5F6-5A3AFE9175C3Q64245587-E9558AE8-7151-4FC0-9DC8-A42129379450Q64249116-DD69B57A-B8DA-4CA8-BC3E-2293CF10FF65
P921
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Immune thrombocytopenia
@ast
Immune thrombocytopenia
@en
Immune thrombocytopenia
@nl
type
label
Immune thrombocytopenia
@ast
Immune thrombocytopenia
@en
Immune thrombocytopenia
@nl
prefLabel
Immune thrombocytopenia
@ast
Immune thrombocytopenia
@en
Immune thrombocytopenia
@nl
P2860
P3181
P1476
Immune thrombocytopenia
@en
P2093
Gaurav Kistangari
Keith R. McCrae
P2860
P304
P3181
P356
10.1016/J.HOC.2013.03.001
P407
P577
2013-06-01T00:00:00Z